Bladder Cancer

Latest News

Pembrolizumab/enfortumab vedotin linked to improvements in patient-reported outcomes
Pembrolizumab/enfortumab vedotin linked to improvements in patient-reported outcomes

January 16th 2024

“These [patient-reported outcome] data are supportive of the use of [enfortumab vedotin plus pembrolizumab] as a 1L therapy option for patients who are cisplatin-ineligible," write the authors.

medical depiction of bladder cancer on xray
Nadofaragene firadenovec now fully available across US for NMIBC

January 16th 2024

medical depiction of a human bladder
Photodynamic therapy TLD-1433 shows initial promise in NMIBC

January 15th 2024

Study launches of eftilagimod alpha plus avelumab in urothelial cancer
Study launches of eftilagimod alpha plus avelumab in urothelial cancer

January 5th 2024

Female doctor working on tablet | Image Credit: © NINENII - stock.adobe.com
Coding Q&A: Billing for female total urethrectomy with complete cystectomy

January 5th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.